Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Wachter DL, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2015 Jan;75(1):72-76.

2.

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.

Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY.

Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143.

3.

Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?

Schulz-Wendtland R, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Brehm B, Hammon M, Saake M, Dankerl P, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2013 May;73(5):422-427.

4.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

5.

Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1135-1138.

6.

Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.

Hein A, Bayer CM, Schrauder MG, Häberle L, Heusinger K, Strick R, Ruebner M, Lux MP, Renner SP, Schulz-Wendtland R, Ekici AB, Hartmann A, Beckmann MW, Fasching PA.

Biomed Res Int. 2014;2014:842452. doi: 10.1155/2014/842452. Epub 2014 Mar 5.

7.

Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.

Wachter DL, Hartmann A, Beckmann MW, Fasching PA, Hein A, Bayer CM, Agaimy A.

Biomed Res Int. 2014;2014:408459. doi: 10.1155/2014/408459. Epub 2014 Feb 19.

8.

Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE study.

Bayer CM, Bani MR, Schneider M, Dammer U, Raabe E, Haeberle L, Faschingbauer F, Schneeberger S, Renner SP, Fischer D, Schulz-Wendtland R, Fasching PA, Beckmann MW, Jud SM.

Eur J Cancer Prev. 2014 May;23(3):151-7. doi: 10.1097/CEJ.0b013e3283651ccb.

PMID:
24100511
9.

Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors.

Lux MP, Bayer CM, Loehberg CR, Fasching PA, Schrauder MG, Bani MR, Häberle L, Engel A, Heusinger K, Tänzer T, Radosavac D, Scharl A, Bauerfeind I, Gesslein J, Schulte H, Overbeck-Schulte B, Beckmann MW, Hein A.

Breast Cancer Res Treat. 2013 Jun;139(2):429-40. doi: 10.1007/s10549-013-2557-3. Epub 2013 May 14.

PMID:
23670130
10.

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.

Loehberg CR, Almstedt K, Jud SM, Haeberle L, Fasching PA, Hack CC, Lux MP, Thiel FC, Schrauder MG, Brunner M, Bayer CM, Hein A, Heusinger K, Heimrich J, Bani MR, Renner SP, Hartmann A, Beckmann MW, Wachter DL.

Breast Cancer Res Treat. 2013 Apr;138(3):899-908. doi: 10.1007/s10549-013-2460-y. Epub 2013 Mar 12.

PMID:
23479421
11.

Factors influencing breast changes after pregnancy.

Rauh C, Faschingbauer F, Haeberle L, Jud SM, Heusinger K, Fasching PA, Goecke TW, Rajakaruna N, Voigt F, Bani MR, Lux MP, Renner SP, Loehberg CR, Hartmann A, Schulz-Wendtland R, Beckmann MW, Bayer CM.

Eur J Cancer Prev. 2013 May;22(3):259-61. doi: 10.1097/CEJ.0b013e328359cb81.

PMID:
23022745
12.

Hormone replacement therapy and prognosis in ovarian cancer patients.

Hein A, Thiel FC, Bayer CM, Fasching PA, Häberle L, Lux MP, Renner SP, Jud SM, Schrauder MG, Müller A, Wachter D, Strehl J, Hartmann A, Beckmann MW, Rauh C.

Eur J Cancer Prev. 2013 Jan;22(1):52-8. doi: 10.1097/CEJ.0b013e328355ec22.

PMID:
22694828
13.

Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se.

Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411.

14.

Characterizing mammographic images by using generic texture features.

Häberle L, Wagner F, Fasching PA, Jud SM, Heusinger K, Loehberg CR, Hein A, Bayer CM, Hack CC, Lux MP, Binder K, Elter M, Münzenmayer C, Schulz-Wendtland R, Meier-Meitinger M, Adamietz BR, Uder M, Beckmann MW, Wittenberg T.

Breast Cancer Res. 2012 Apr 10;14(2):R59.

15.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

16.

Breast Cancer Risk - Genes, Environment and Clinics.

Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1056-1066.

17.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, Rauh C, Schulz-Wendtland R, Bani MR, Schrauder M, Kahmann L, Lux MP, Strehl JD, Hartmann A, Dimmler A, Beckmann MW, Wachter DL.

BMC Cancer. 2011 Nov 14;11:486. doi: 10.1186/1471-2407-11-486.

18.

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients.

Meier-Meitinger M, Rauh C, Adamietz B, Fasching PA, Schwab SA, Haeberle L, Hein A, Bayer CM, Bani MR, Lux MP, Hartmann A, Wachter DL, Uder M, Schulz-Wendtland R, Beckmann MW, Heusinger K.

Eur J Surg Oncol. 2012 Jan;38(1):44-51. doi: 10.1016/j.ejso.2011.10.008. Epub 2011 Oct 26.

PMID:
22032911
19.

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.

Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, Benítez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, Lanng C, Grenaker Alnæs G, Kristensen V, Børrensen-Dale AL, Hopper JL, Dite GS, Apicella C, Southey MC, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Chang-Claude J, Wang-Gohrke S, Radice P, Peterlongo P, Manoukian S, Barile M, Giles GG, Baglietto L, John EM, Miron A, Chanock SJ, Lissowska J, Sherman ME, Figueroa JD, Bogdanova NV, Antonenkova NN, Zalutsky IV, Rogov YI, Fasching PA, Bayer CM, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Meindl A, Heil J, Bartram CR, Schmutzler RK, Thomas GD, Hoover RN, Fletcher O, Gibson LJ, dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks A, Van 't Veer LJ, Tollenaar RA, Pharoah PD, Dunning AM, Pooley KA, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindstrom S, Chen X, Beesley J, Hamann U, Harth V, Justenhoven C; GENICA Network, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, Wang X, Humphreys MK, Wang Q, Chenevix-Trench G; kConFab Investigators; AOCS Group, Easton DF.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2222-31. doi: 10.1158/1055-9965.EPI-11-0569. Epub 2011 Jul 27.

20.

Diabetes and prognosis in a breast cancer cohort.

Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR.

J Cancer Res Clin Oncol. 2011 Jun;137(6):975-83. doi: 10.1007/s00432-010-0960-2. Epub 2010 Dec 5.

PMID:
21132511
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk